Investors' belief that Zhuhai Rundu Pharmaceutical will unde...
Investors' belief that Zhuhai Rundu Pharmaceutical will underperform the broader market may explain its low P/E ratio. If recent medium-term earnings trends persist, the share price is unlikely to see significant movement soon.
![](https://pubimg-10000538.picsh.myqcloud.com/20220509000001973a46cb09e90.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment